This is to inform you that the Company has entered into a Business Transfer Agreement dated 06 January 2025 with M/s. Rubicon Research Limited the details of which are enclosed herewith.

The Price to Earnings (P/E) ratio, a key valuation measure, is calculated by dividing the stock's most recent closing price by the sum of the diluted earnings per share from continuing operations ...

Pfizer Inc. asked a federal court in Delaware to block copies of blockbuster arthritis drug Xeljanz proposed by Alkem Laboratories Ltd. that it said infringe a patent expiring this year. Alkem’s ...

With foreign institutional investor headroom in HDFC Bank remaining above 20% in the quarter ended September, India's largest private-sector bank is set to attract an additional $1.8 billion in ...

Alkem Laboratories Ltd. is an India-based pharmaceutical company with global operations, engaged in the development, manufacturing and sale of pharmaceutical and nutraceutical products. The ...

Analysts have given recommendations for companies including ITC Ltd., Devyani International Ltd., Sun Pharmaceutical Industries Ltd., Alkem Laboratories Ltd., and more. As per the stock calls shared ...

The apartment has been purchased by Seema Singh, promoter of Alkem Laboratories. The property, located on the 30th floor, Apartment No. 3001, A-Wing, has set a new benchmark in Mumbai’s high-end ...

Alkem Laboratories has raised Rs 395 crore from anchor investors, including Abu Dhabi Investment Fund, by allotting shares at a price of Rs 1,050. For the IPO, the company has fixed a price band ...